Anadolu Medical Center
| Turquia | Áustria | Espanha | |
| NanoKnife | de $9,500 | de $25,000 | de $12,000 |
A Bookimed não adiciona taxas extras aos preços de NanoKnife. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em NanoKnife e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de NanoKnife.
Dia 1 - Chegada
Dia 2 - Pré-Operatório
Dia 3 - Pré-Operatório
Dia 4 - Procedimento NanoKnife
Dia 5 - Pós-Operatório
Semana 1 - Reabilitação
Semanas 2-4 - Reabilitação
Semanas 5-6 - Reabilitação
Por favor, note que o tempo de recuperação de cada paciente pode variar dependendo da sua condição de saúde individual, do tamanho e localização do tumor e da sua condição física geral. Considere sempre consultar os seus médicos e seguir seus conselhos para o melhor resultado possível.
O Dr. Solak é especializado no tratamento de vários tipos de câncer, incluindo câncer de mama, pulmão e gastrointestinal, com extensa formação nas principais instituições.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
É especialista em cirurgias robóticas e laparoscópicas, incluindo procedimentos avançados como a Prostatectomia Radical Robótica e a Sacrocolpopexia Laparoscópica no İstinye University Liv Hospital Topkapı.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.